Progyny earnings were $78.6M for the trailing 12 months ending Jun 30, 2026, with 57.4% growth year over year. The latest PGNY earnings report on Jun 30, 2026 announced Q2 2026 earnings of $28.1M, up 15.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PGNY reported annual earnings of $58.5M, with 7.7% growth.
PGNY past earnings growth
How has PGNY's earnings growth performed historically?
On PGNY's earnings call on Aug 6, 2026, Progyny (NASDAQ: PGNY) reported Q2 2026 earnings per share (EPS) of $0.36, up 80% year over year. Total PGNY earnings for the quarter were $28.05 million. In the same quarter last year, Progyny's earnings per share (EPS) was $0.20.
As of the last Progyny earnings report, Progyny is currently profitable. Progyny's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $78.63 million, a 48.02% increase year over year.
What was PGNY's earnings growth in the past year?
As of Progyny's earnings date in Aug 6, 2026, Progyny's earnings has grown 57.38% year over year. This is 4.42 percentage points lower than the US Health Information Services industry earnings growth rate of 61.8%. PGNY earnings in the past year totalled $78.63 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.